Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Wiegman

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Atherosclerosis|January 28, 2021
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countriesMarta Futema, Uma Ramaswami, Lukas Tichy, et al.
Atherosclerosis|March 22, 2020
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registryIlse K Luirink, Barbara A Hutten, Susanne Greber-Platzer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
Atherosclerosis|April 10, 2024
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
European Journal of Preventive Cardiology|April 30, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
International Journal of Cardiology|January 15, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
European Heart Journal|May 25, 2026
Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statementAlbert Wiegman, Mafalda Bourbon, Tomas Freiberger, et al.
Clinical Chemistry|November 22, 2014
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countriesMarta Futema, Sonia Shah, Jackie A Cooper, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Atherosclerosis|January 28, 2021
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countriesMarta Futema, Uma Ramaswami, Lukas Tichy, et al.
Atherosclerosis|March 22, 2020
Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registryIlse K Luirink, Barbara A Hutten, Susanne Greber-Platzer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
Atherosclerosis|April 10, 2024
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
European Journal of Preventive Cardiology|April 30, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
International Journal of Cardiology|January 15, 2014
Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationGerald F Watts, Samuel Gidding, Anthony S Wierzbicki, et al.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
European Heart Journal|May 25, 2026
Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statementAlbert Wiegman, Mafalda Bourbon, Tomas Freiberger, et al.
Clinical Chemistry|November 22, 2014
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countriesMarta Futema, Sonia Shah, Jackie A Cooper, et al.
Pageof 13